U.S., April 11 -- ClinicalTrials.gov registry received information related to the study (NCT06922045) titled 'Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients' on March 13.
Brief Summary: This study will assess the efficacy of multiple-dose of STSP-0601 for the treatment of bleeding episodes in hemophilia A or B patients with inhibitor
Study Start Date: March 26
Study Type: INTERVENTIONAL
Condition:
Hemophilia
Intervention:
DRUG: STSP-0601 for Injection
Evaluation of the Efficacy of Single-Dose and Continuous Administration of STSP-0601 Injection for the Treatment of Bleeding in Patients with Hemophilia A or B with Inhibitors
Recruitment Status: RECRUITING
Sponsor: Jiangsu BioJeTay Biotechnology Co., Ltd....